Global Hematology Analyzer Market Analysis 2013-2017 & 2018-2023 by Type (3-part, 5-part, 6-part), Modality (POC, Standalone), End User, & Region - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 8, 2019--The “Global Hematology Analyzer Market: Analysis By Type (3-part, 5-part, 6-part), By Modality (POC, Standalone), By End User, By Region, By Country (2018 Edition): Opportunities and Forecast (2013-2023)” report has been added to ResearchAndMarkets.com’s offering.
Global hematology analyzer market is projected to display a robust growth represented by a CAGR of 5.85% during 2018-2023. The market has been assessed for the historical period of 2013-2017 and the forecast period of 2018-2023.
Over the recent years, Hematology Analyzer market has been witnessing growth, on account of several driving factors including improvements in analytical capabilities, rise in demand for hematology analyzers with lesser operator intervention, increase in demand for POC hematology analyzers, and growing compatibility with electronic medical record system. Moreover, rapidly increasing number of hospitals and diagnostics laboratories due to surging prevalence of chronic diseases, cancer, vector borne diseases, and blood disorders have been driving the market growth. In addition, rising geriatric population, increasing global healthcare expenditure and technological advancements in medical research has been contributing in the market growth of the hematology analyzers.
In this research report, the market is segmented on the basis of product type, modality as well as end user. By product type, the 3-part hematology analyzers are predicted to hold their dominant position in the market. By modality, standalone hematology analyzers are anticipated to creates their dominance in global hematology analyzer market, while POC hematology analyzers are expected to witness fastest growth. By end users, hospital segment is anticipated to provide the maximum revenue to the hematology analyzer manufacturers. Amongst the regions, North America accounts for the largest regional share in the global hematology market in 2017. The largest share of North America is attributed to presence of enormous number of patient base and highly advanced medical infrastructure.
The report has covered and analysed the potential of hematology analyzer market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the hematology analyzer market. Additionally, the report also highlights market entry strategies for various companies across the globe.
Scope of the Report
Global Hematology Analyzer Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)Hematology Analyzer Market- Size, Growth, Forecast Analysis By Type- 3-Part Differential Hematology Analyzer, 5-Part Differential Hematology Analyzer, 6-Part Differential Hematology Analyzer. Analysis By Modality - Standalone Hematology Analyzer, Point-of-Care Hematology Analyzer. Analysis By End Users - Hospitals, Diagnostics Laboratories, Others
Company ProfilesSysmex Nihon Kohden Boule Diagnostics HORIBA Beckman Coulters Abbott Laboratories Siemens EKF Diagnostics Bio-Rad Drew Scientific BioSystems
For more information about this report visit https://www.researchandmarkets.com/research/cw8kx9/global_hematology?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190108005456/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 01/08/2019 05:23 AM/DISC: 01/08/2019 05:23 AM